Nabriva Therapeutics (NBRVF) Q3 2020 Earnings

5NovExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-0.98
-0.7
-0.42
-0.14

Details

Expected EPS
-0.975
Actual EPS
-0.9
Surprise EPS
0.07
Surprise Percent
+7.69%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.9 per share for Q3 2020.

0 Comments

Share your thoughts